Search research articles
Contact Us
Filters
Showing results (101-110 of 189) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2017
Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide
Carla Calagua, Joshua Russo, Yue Sun, et al.
Cancer Research
|
March 6, 2023
LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer
Muqing Li, Mingyu Liu, Wanting Han, et al.
Cancer Letters
|
September 16, 2018
Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer
Joshua W Russo, Xiaming Liu, Huihui Ye, et al.
JCO Precision Oncology
|
September 27, 2021
Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors
David J Einstein, Seiji Arai, Carla Calagua, et al.
Experimental Dermatology
|
April 7, 2005
CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity
Edward E S Nieuwenhuis, Silke Gillessen, Rik J Scheper, et al.
Endocrine-Related Cancer
|
July 1, 2017
Testicular vs adrenal sources of hydroxy-androgens in prostate cancer
Tianzhu Zang, Mary-Ellen Taplin, Daniel Tamae, et al.
Cell Reports
|
October 21, 2016
Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein
Shuai Gao, Yanfei Gao, Housheng Hansen He, et al.
The Journal of Clinical Investigation
|
April 5, 2016
SOX9 drives WNT pathway activation in prostate cancer
Fen Ma, Huihui Ye, Housheng Hansen He, et al.
Journal of Clinical and Translational Pathology
|
October 4, 2024
Androgen Drives the Expression of SARS-CoV-2 Entry Proteins in Sinonasal Tissue
Rong Rong Huang, Jenna M Giafaglione, Takao Hashimoto, et al.
Cancer Research
|
August 27, 2011
Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors
Changmeng Cai, Sen Chen, Patrick Ng, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 189) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2017
Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide
Carla Calagua, Joshua Russo, Yue Sun, et al.
Cancer Research
|
March 6, 2023
LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer
Muqing Li, Mingyu Liu, Wanting Han, et al.
Cancer Letters
|
September 16, 2018
Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer
Joshua W Russo, Xiaming Liu, Huihui Ye, et al.
JCO Precision Oncology
|
September 27, 2021
Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors
David J Einstein, Seiji Arai, Carla Calagua, et al.
Experimental Dermatology
|
April 7, 2005
CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity
Edward E S Nieuwenhuis, Silke Gillessen, Rik J Scheper, et al.
Endocrine-Related Cancer
|
July 1, 2017
Testicular vs adrenal sources of hydroxy-androgens in prostate cancer
Tianzhu Zang, Mary-Ellen Taplin, Daniel Tamae, et al.
Cell Reports
|
October 21, 2016
Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein
Shuai Gao, Yanfei Gao, Housheng Hansen He, et al.
The Journal of Clinical Investigation
|
April 5, 2016
SOX9 drives WNT pathway activation in prostate cancer
Fen Ma, Huihui Ye, Housheng Hansen He, et al.
Journal of Clinical and Translational Pathology
|
October 4, 2024
Androgen Drives the Expression of SARS-CoV-2 Entry Proteins in Sinonasal Tissue
Rong Rong Huang, Jenna M Giafaglione, Takao Hashimoto, et al.
Cancer Research
|
August 27, 2011
Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors
Changmeng Cai, Sen Chen, Patrick Ng, et al.
Page
of 19